Loading institutional data...
Loading institutional data...
Held by 898 of 5,944 reporting institutions (99th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $59.03 today, the market must believe free cash flow compounds -4.7%/yr for a decade (off $1.9B normalized FCF).
The market's -4.7% is more optimistic than its 9-yr track record.
2-stage DCF · 0.32B shares · net debt -$3.2B
mean 6.4% · volatility σ 111% · implied rate exceeded in 2/9 yrs
Central path = implied -4.7%/yr growth; shaded band = ±1σ (111%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Ranked against 259 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LIN | $230.5B | 33.6× | 20.6× | 6.8× | 3.0% | — | 20.3% | 18.0% | 10.9% | 2.1× | 2,148 |
| BHPLF | $220.3B | — | — | — | — | — | — | — | — | — | 6 |
| SCCO | $162.8B | 37.6× | 21.0× | 12.1× | 17.4% | 60.1% | 32.3% | 39.3% | 24.4% | 0.9× | 791 |
| TX | $107.7B | — | — | — | — | — | — | — | — | — | 139 |
| FCX | $99.7B | — | 12.0× | 3.9× | 1.8% | 28.2% | 8.5% | 11.7% | 7.9% | 1.0× | 1,775 |
| SHW | $91.6B | 36.0× | — | 3.9× | 2.1% | 48.8% | 10.9% | 55.9% | 17.0% | — | 1,610 |
| AEM | $82.8B | — | — | — | — | — | — | — | — | — | 1,066 |
| ECL | $80.5B | 39.2× | 23.7× | 5.0× | 2.2% | 44.5% | 12.9% | 21.2% | 19.5% | 0.3× | 1,619 |
| B | $68.8B | — | — | — | — | — | — | — | — | — | 979 |
| CRH | $66.9B | 18.1× | 10.4× | 1.8× | 5.3% | 36.1% | 10.0% | 15.6% | 9.2% | 2.2× | 9 |
| APD | $65.7B | — | 92.9× | 5.5× | -0.5% | 31.4% | -3.3% | -2.6% | -2.6% | 0.1× | 1,702 |
| VALE | $63.6B | — | — | — | — | — | — | — | — | — | 537 |
| SYAXF | $63.5B | — | — | — | — | — | — | — | — | — | — |
| DD | $61.5B | — | — | 9.0× | 1.9% | 34.5% | 1.3% | 0.6% | 0.6% | — | 1,172 |
| WPM | $55.8B | — | — | — | — | — | — | — | — | — | 809 |
| AU | $44.7B | — | — | — | — | — | — | — | — | — | 537 |
| FNV | $43.7B | — | — | — | — | — | — | — | — | — | 614 |
| STLD | $38.5B | 33.3× | 20.7× | 2.1× | 3.6% | 13.2% | 6.5% | 13.2% | 9.0% | 2.1× | 893 |
| VMC | $37.5B | 35.4× | 17.6× | 4.7× | 7.1% | 27.4% | 13.6% | 12.6% | 8.4% | 1.8× | 981 |
| MLM | $33.4B | 29.5× | 18.6× | 5.4× | 8.6% | 30.7% | 18.5% | 11.3% | 7.4% | 2.6× | 1,022 |
| TCKRF | $32.4B | — | — | — | — | — | — | — | — | — | 8 |
| NTR | $32.1B | — | — | — | — | — | — | — | — | — | 718 |
| AMRZ | $29.2B | 24.7× | 12.1× | 2.5× | 0.9% | 25.7% | 10.0% | 8.9% | 6.5% | 1.9× | 433 |
| GFIOF | $28.7B | — | — | — | — | — | — | — | — | — | 4 |
| PPG | $26.6B | 17.2× | — | 1.7× | 0.2% | 41.3% | 9.9% | 19.8% | 10.8% | — | 1,003 |
| LYB | $19.0B | — | 16.3× | 0.6× | -9.7% | 8.5% | -2.4% | -7.3% | -7.2% | 0.2× | 898 |
Peers = companies sharing LYB's sector (Basic Materials) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Insufficient balance-sheet detail (needs retained earnings, working capital, equity).
Needs granular two-year detail (receivables, PP&E, D&A, SG&A) — not fully reported.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage rising year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
The dividend exceeds free cash flow (459%) — funded from the balance sheet or debt, a red flag if it persists. Last year: $1.8B dividends + $201M buybacks = $2.0B returned on $384M FCF.
2 consecutive years of dividend increases · 5%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A balanced mix of reinvestment and shareholder returns.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -7%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $3.4B covers the $816M due within a year 4.2× over. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~215.5% on $226M of debt.
Cash of $3.4B fully covers short-term debt of $226M.
Mostly short-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-08-05
Where each multiple sits in its own 14-yr range · 67th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 12.6× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 83.4 | 84.4 | 87.8 | 81.0 | 86.9 | 85.3 | 86.1 | 91.5 |
| R&D | 0.3 | 0.3 | 0.4 | 0.3 | 0.2 | 0.4 | 0.4 | 0.5 |
| SG&A | 2.9 | 3.5 | 4.1 | 2.7 | 2.6 | 4.6 | 4.9 | 5.3 |
| Operating Income | 13.4 | 11.9 | 5.6 | 14.7 | 10.1 | 8.2 | 5.7 | -1.4 |
| Income Tax | 1.6 | 1.9 | -0.2 | 2.5 | 1.7 | 1.3 | 0.8 | 0.2 |
| Net Income | 12.0 | 9.8 | 5.1 | 12.2 | 7.7 | 6.4 | 4.1 | -2.4 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on LYB: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
EOD close · as of 2026-08-05 · 15d old
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $30.15B 100.0% | $33.39B 100.0% | $33.34B 100.0% | $50.45B 100.0% | $46.17B 100.0% | $27.75B 100.0% | $34.73B 100.0% | $39.00B 100.0% | $34.48B 100.0% | $29.18B 100.0% |
| Cost of Revenue | $27.58B 91.5% | $28.75B 86.1% | $28.43B 85.3% | $43.85B 86.9% | $37.40B 81.0% | $24.36B 87.8% | $29.30B 84.4% | $32.53B 83.4% | $28.06B 81.4% | $23.19B 79.5% |
| Cost of Products | — | — | — | — | — | — | — | — | $28.06B 81.4% | $23.19B 79.5% |
| Research & Development | $136.0M 0.5% | $135.0M 0.4% | $130.0M 0.4% | $124.0M 0.2% | $124.0M 0.3% | $113.0M 0.4% | $111.0M 0.3% | $115.0M 0.3% | $106.0M 0.3% | $99.0M 0.3% |
| Selling, General & Admin | $1.61B 5.3% | $1.64B 4.9% | $1.54B 4.6% | $1.31B 2.6% | $1.25B 2.7% | $1.14B 4.1% | $1.20B 3.5% | $1.13B 2.9% | $859.0M 2.5% | $833.0M 2.9% |
| Total Operating Expenses | $30.57B 101.4% | $31.48B 94.3% | $30.61B 91.8% | $45.35B 89.9% | $39.40B 85.3% | $26.19B 94.4% | $30.61B 88.1% | $33.77B 86.6% | $29.02B 84.2% | $24.12B 82.7% |
| Operating Income | -$420.0M -1.4% | $1.92B 5.7% | $2.73B 8.2% | $5.10B 10.1% | $6.77B 14.7% | $1.56B 5.6% | $4.12B 11.9% | $5.23B 13.4% | $5.46B 15.8% | $5.06B 17.3% |
| Interest Expense | $487.0M 1.6% | $481.0M 1.4% | $477.0M 1.4% | $287.0M 0.6% | $519.0M 1.1% | $526.0M 1.9% | $347.0M 1.0% | $360.0M 0.9% | $491.0M 1.4% | $322.0M 1.1% |
| Interest & Investment Income | $97.0M 0.3% | $150.0M 0.4% | $129.0M 0.4% | $29.0M 0.1% | $9.0M 0.0% | $12.0M 0.0% | $19.0M 0.1% | $45.0M 0.1% | $24.0M 0.1% | $17.0M 0.1% |
| Other Income (Expense), net | $113.0M 0.4% | $47.0M 0.1% | -$58.0M -0.2% | -$72.0M -0.1% | $62.0M 0.1% | $85.0M 0.3% | $39.0M 0.1% | $106.0M 0.3% | $179.0M 0.5% | $111.0M 0.4% |
| Pretax Income | -$715.0M -2.4% | $1.70B 5.1% | $2.30B 6.9% | $4.78B 9.5% | $6.79B 14.7% | $1.39B 5.0% | $4.05B 11.7% | $5.31B 13.6% | $5.49B 15.9% | $5.23B 17.9% |
| Income Tax Expense | $70.0M 0.2% | $259.0M 0.8% | $433.0M 1.3% | $882.0M 1.7% | $1.16B 2.5% | -$43.0M -0.2% | $648.0M 1.9% | $613.0M 1.6% | $598.0M 1.7% | $1.39B 4.7% |
| Net Income | -$738.0M -2.4% | $1.37B 4.1% | $2.12B 6.4% | $3.89B 7.7% | $5.62B 12.2% | $1.43B 5.1% | $3.40B 9.8% | $4.69B 12.0% | $4.88B 14.1% | $3.84B 13.1% |
| Per Share | ||||||||||
| EPS (Basic) | $-2.34 | $4.16 | $6.48 | $11.84 | $16.77 | $4.24 | $9.59 | $12.04 | $12.23 | $9.15 |
| EPS (Diluted) | $-2.34 | $4.15 | $6.46 | $11.81 | $16.75 | $4.24 | $9.58 | $12.01 | $12.23 | $9.13 |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.